health

Online Webast Series Teaches On Health Screening for Non-Malignant Diseases

by

OSUWexnerbloglogo2014 Online Webast Teaches On Health Screening for Non-Malignant Diseases. On this CME webcast, we are going to be discussing current recommendations for health screening with a focus on screening for non-cancer conditions. First, to tell us about screening in children is Assistant Professor of Family Medicine, Dr. Rachel McGuirk. And then to update us about health screening in adults is Assistant Professor of Family Medicine, Dr. Sondos Al Sad.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: discuss the role of the USPSTF and how to interpret their recommendations; review pediatric preventative measures including physical examination, screening questionnaires, laboratory testing, and behavioral interventions; recognize top health screenings that impact morbidity and mortality of general population; and prioritize preventive health screenings based on informed discussion with patients.

You’ll also learn about the following:

  • What age screening should start
  • Where screening guidelines come from
  • The childhood growth chart
  • Which lipid tests you should order
  • Dementia screening
  • Tests used for syphilis and other sexually-transmitted diseases

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Gain A Better Understanding of Psoriasis on CME Webcast

by

OSUWexnerbloglogo2014 Gain A Better Understanding of Psoriasis on CME Webcast. Over the centuries, thousands of treatments have been tried and thousands of treatments have failed. But the good news is that in the past few years there have been effective new biologic agents developed that are offering hope to patients with the most severe cases of psoriasis. Joining us on our webcast to discuss the diagnosis and management of psoriasis is dermatologist and Assistant Professor of Internal Medicine, Dr. Jessica Kaffenberger.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the different types of psoriasis and how to effectively treat them; DESCRIBE the pathogenesis of psoriasis and how it correlates with the newest therapies; and IDENTIFY frequent psoriasis co-morbidities that affect medication management.

You’ll also learn about the following:

  • The etiology of psoriasis
  • New directions in treating psoriasis
  • The role of skin biopsy
  • Psoriasis versus eczema
  • Long-term prognosis for patients with psoriasis
  • Relationship of diet, exercise, and sunlight with psoriasis
  • Deodorants and common skin lotions
  • Swimming with psoriasis
  • Treatment of psoriatic arthritis
  • Precautions for patients taking methotrexate
  • Genital psoriasis and sexual health

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Enduring Material Discusses Update On Cancer Survivorship Principles In Primary Care

by

OSUWexnerbloglogo2014 On-line Enduring Material Discusses Update On Cancer Survivorship Principles In Primary Care. On this CME webcast, we’re going to learn about the special needs of cancer survivors. We’re delighted to welcome medical oncologist and Associate Professor of Internal Medicine from the Ohio State University and James Cancer Hospital, Dr. Maryam Lustberg. And also general internist, pediatrician, and Assistant Professor of Internal Medicine from OSU, Dr. Heather Saha.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the needs of cancer survivors throughout the cancer continuum; DISCUSS way to improve PCP and oncologist collaboration and communication.

You’ll also learn about the following:

  • The role of the primary care physician in cancer survivorship
  • Managing fatigue in the cancer survivor
  • Special considerations for survivors of pediatric cancers
  • Healthy diets for cancer survivors
  • Chemotherapy and peripheral neuropathy
  • Radiation effects on long-term health
  • Economic and financial implications of being a cancer survivor
  • Cancer survivors and sexual health
  • Cancers that can have late relapse

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Immunosuppressant Medications

by

OSUWexnerbloglogo2014 CME Webcast Teaches on Immunosuppressant Medications. More and more, primary care physicians and hospitalists are finding themselves taking care of patients who have been started on immunosuppressant medication a transplant physician, rheumatologist, nephrologist, or pulmonologist. On this CME webcast, we’re going to tell you what you need to know about these medications, their side effects, and their complications. Let me introduce our guests. Dr. Brian Keller is a lung transplant pulmonologist and Assistant Professor Internal Medicine at The Ohio State University. And Pamela Burcham is a lung transplant specialty pharmacist from the OSU Wexner Medical Center.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS indications for immunosuppressive therapies; and DESCRIBE prophylaxis immunization, and pregnancy considerations for patients on Immunosuppressive therapy; UNDERSTAND the indications for individual immunosuppressants; and DESCRIBE the common adverse effects and monitoring parameters of the immunosuppressive medications.

You’ll also learn about the following:

  • Common indications for immunosuppressant medications
  • Commonly used immunosuppressant medications
  • Food safety for patients taking immunosuppressant medications
  • Pneumocystis jiroveci clinical presentation
  • Indications for TNF inhibitors
  • Infection risk of TNF inhibitors
  • Management of immunosuppressants in the perioperative period
  • Travel safety when taking an immunosuppressant
  • Bone health and corticosteroids
  • Eye health and corticosteroids
  • Monitoring for methotrexate-induced hepatotoxicity
  • Thiopurine methylytransferase
  • Cyclophosphamide

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Enduring Material Teaches Physicians on Inflammatory Bowel Disease

by

OSUWexnerbloglogo2014 On-line CME Enduring Material Teaches Physicians on Inflammatory Bowel Disease. We have come a long way since Crohn, Ginzburg, and Oppenheimer first described inflammatory bowel disease. On this CME Webcast, we’re going to bring you up to date on Crohn’s disease and ulcerative colitis, what they are, how to diagnose them and new treatments for inflammatory bowel disease. We’re pleased to have the Medical Director of the OSU Inflammatory Bowel Disease Center, gastroenterologist and Assistant Professor of Internal Medicine, Dr. Anita Afzali joining us on the program.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the role of the primary care provider (PCP) in IBD; and DEVELOP a health maintenance plan for the patient with IBD.

You’ll also learn about the following:

  • Etiology of inflammatory bowel disease
  • New developments in treatment of inflammatory bowel disease
  • Diet and inflammatory bowel disease
  • Pregnancy and inflammatory bowel disease
  • Management of small bowel obstruction and acute exacerbations of pain
  • Duration of biologic therapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.